A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition - Concepedia

Concepedia

Publication | Closed Access

A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition

54

Citations

22

References

2003

Year

Anthony Clarke, E S Johnson, Nicholas Mallard, T. H. Corn, A. E. Johnston, Malcolm Boyce, Steve Warrington, Douglas G MacMahon

Journal of Neural Transmission

Pharmacological StudyNew Low-dose FormulationPharmacologyMao-b InhibitionPharmacological AgentNeuropharmacologyPharmacotherapyMedicineClinical EfficacyDrug Discovery

References

	Year	Citations

Page 1

Page 1